SCHEMBL9545575

SCHEMBL9545575

CN1C(=O)[C@H](NC(=O)Nc2cccc(Nc3nnn[nH]3)c2)N=C(c2ccccc2)c2ccccc21

nearest known ligand 0.78

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 18/20 0.74
KCNH2 Q12809 1/20 0.70
CCKAR P32238 4/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9271166 0.89 CCKBR (0.76) CCKBRKCNH2
SCHEMBL8542118 0.88 CCKBR (0.77) CCKBRKCNH2CCKAR
SCHEMBL9545577 0.88 CCKBR (0.78) CCKBRKCNH2
SCHEMBL9545582 0.84 CCKBR (0.76) CCKBRKCNH2CCKAR
SCHEMBL9278492 0.84 CCKBR (0.76) CCKBR
SCHEMBL9866668 0.84 CCKBR (1.00) CCKBRKCNH2
L-365260 SCHEMBL29403509 0.82 CCKBR (1.00) CCKBRKCNH2
L-365260 SCHEMBL31616010 0.82 CCKBR (1.00) CCKBRKCNH2
L-365260 SCHEMBL29694194 0.82 CCKBR (1.00) CCKBRKCNH2
L-365260 SCHEMBL9843248 0.82 CCKBR (1.00) CCKBRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1993019052-A1 3-UREIDO SUBSTITUTED BENZODIAZEPIN-2-ONES HAVING CHOLECYSTOKININ AND/OR GASTRIN ANTAGONISTIC ACTIVITY AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-09-30 WO claimed
WO-1993019052-A1 3-UREIDO SUBSTITUTED BENZODIAZEPIN-2-ONES HAVING CHOLECYSTOKININ AND/OR GASTRIN ANTAGONISTIC ACTIVITY AND THEIR USE IN THERAPY MERCK SHARP & DOHME LIMITED (GB) 1993-09-30 WO disclosed